Safety Monitoring Considerations in Early Phase AAV-based Gene Therapy Trials Targeting CNS Disorders

Time: 10:00 am
day: Day Two


  • Signs of adverse events can arise during clinical trials, this presentation will provide a comprehensive overview of best practice for detecting, evaluating and monitoring safety signals in the clinic
  • Including what to look for, how often to monitor safety signals observed and how to interpret the data
  • Strategies to overcome unexpected safety data observed in the clinic